Check your understanding of the course by completing this final quiz. You can download an answer key at the bottom of the page.
Q1. What is a multidrug-resistant bacterium or a “superbug”?
- A very pathogenic bacterium capable of causing life-threatening infections.
- A bacterium that is resistant to several antibiotic
Q2. What areas of the world suffer most from the burden of antibiotic resistance?
- Low- and middle-income countries
- High-income countries
- The problem is equally severe in all parts of the world
Q3. Why is antibiotic treatment often not used for mild throat or skin infections?
- Skin and throat infections are always caused by viruses.
- All bacteria causing these types of infections are already resistant to the relevant antibiotics.
- The human immune system can often clear these kinds of infections on its own.
Q4. Why are antibiotics used in livestock production and animal farming?
- They are not used at all.
- They are only used for treatment of infected animals.
- They are used for treatment and prevention of disease and for growth promotion.
Q5. How much of the human use of antibiotics is unnecessary?
- Almost none.
- About 50%.
- About 20%.
Q6. Could vaccination against viral diseases slow down the antibiotic resistance development?
- No. Protection from viral diseases has nothing to do with antibiotic resistance development since antibiotics are only used for treating bacterial infections.
- Yes. Protection from viral diseases will decrease the use of antibiotics, which in turn will affect the antibiotic resistance development.
Q7. In poor countries, insufficient access to antibiotics is currently a bigger problem than antibiotic resistance.
Q8. There is not much I can do to affect antibiotic resistance development.
More from "Part 4"
- A global problem
- What do we need to do for the future?
- Global initiatives to fight antibiotic resistance
- What can I do?
- Resistance quiz
- Panel discussion
- Where do you think we will be in 50 years?
- Test your understanding IV
- Reflection and analysis: engaging the general public
- End of course
- Thank you and farewell